APA

Nazha A., Al-Issa K., Hamilton B. K., Radivoyevitch T., Gerds A. T., Mukherjee S., Adema V., Zarzour A., Abuhadra N., Patel B. J., Hirsch C. M., Advani A., Przychodzen B., Carraway H. E., Maciejewski J. P. & Sekeres M. A. (20180604). Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes. : Leukemia.

Chicago

Nazha A, Al-Issa K, Hamilton B K, Radivoyevitch T, Gerds A T, Mukherjee S, Adema V, Zarzour A, Abuhadra N, Patel B J, Hirsch C M, Advani A, Przychodzen B, Carraway H E, Maciejewski J P and Sekeres M A. 20180604. Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes. : Leukemia.

Harvard

Nazha A., Al-Issa K., Hamilton B. K., Radivoyevitch T., Gerds A. T., Mukherjee S., Adema V., Zarzour A., Abuhadra N., Patel B. J., Hirsch C. M., Advani A., Przychodzen B., Carraway H. E., Maciejewski J. P. and Sekeres M. A. (20180604). Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes. : Leukemia.

MLA

Nazha A, Al-Issa K, Hamilton B K, Radivoyevitch T, Gerds A T, Mukherjee S, Adema V, Zarzour A, Abuhadra N, Patel B J, Hirsch C M, Advani A, Przychodzen B, Carraway H E, Maciejewski J P and Sekeres M A. Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes. : Leukemia. 20180604.